WallStreetZenWallStreetZen

NASDAQ: VRNA
Verona Pharma PLC Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Verona Pharma earnings were -$163.9M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest VRNA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$16.3M, down 51.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VRNA reported annual earnings of -$173.4M, with 219% growth.

VRNA earnings history

Current Revenue
$118.5M
Current Earnings
-$163.9M
Current Profit Margin
-138.3%

VRNA Return on Equity

Current Company
-89.8%
Current Industry
1.9%
Current Market
25%
VRNA's Return on Equity (-89.8%)... subscribe to Premium to read more.
High Return on Equity Performance

VRNA undefined

Current Company
-36.1%
Current Industry
0.9%
VRNA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when VRNA announces earnings.

VRNA undefined

Current Company
-26.1%
Current Industry
3.6%
VRNA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VRNA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
VRNA-$121.41M-$163.94MN/A-$2.00
SRPT$314.67M$235.24MN/A$2.47
LEGN-$113.16M-$177.03MN/A-$0.96
TLX$58.49M$31.40MN/AN/A
BPMC-$11.50M-$67.09MN/A-$1.07
View Top Biotech Stocks

Verona Pharma Earnings Reports & History FAQ

What were Verona Pharma's earnings last quarter?

On VRNA's earnings call on Invalid Date, Verona Pharma (NASDAQ: VRNA) reported Q1 2025 earnings per share (EPS) of -$0.16, up 50% year over year. Total VRNA earnings for the quarter were -$16.32 million. In the same quarter last year, Verona Pharma's earnings per share (EPS) was -$0.32.

If you're new to stock investing, here's how to buy Verona Pharma stock.

Is Verona Pharma profitable or losing money?

As of the last Verona Pharma earnings report, Verona Pharma is currently losing money. Verona Pharma's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$163.94 million, a 158.5% increase year over year.

What was VRNA's earnings growth in the past year?

As of Verona Pharma's earnings date in Invalid Date, Verona Pharma's earnings has grown year over year. VRNA earnings in the past year totalled -$163.94 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.